Cargando…
[(18)F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials
INTRODUCTION: The presence of hypoxia in head-and-neck squamous cell carcinoma is a negative prognostic factor. PET imaging with [18F] HX4 can be used to visualize hypoxia, but it is currently unknown how this correlates with prognosis. We investigated the prognostic value of [18F] HX4 PET imaging i...
Autores principales: | Sanduleanu, Sebastian, Hamming-Vrieze, Olga, Wesseling, Frederik W.R., Even, Aniek J.G., Hoebers, Frank J., Hoeben, Ann, Vogel, Wouter V., Tesselaar, Margot E.T., Parvin, Daniel, Bartelink, Harry, Lambin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184102/ https://www.ncbi.nlm.nih.gov/pubmed/32368624 http://dx.doi.org/10.1016/j.ctro.2020.04.004 |
Ejemplares similares
-
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
por: Even, Aniek J.G., et al.
Publicado: (2016) -
Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
Evaluation of tumour hypoxia during radiotherapy using [(18)F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
por: Zegers, Catharina M. L., et al.
Publicado: (2016) -
Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
por: Zegers, Catharina M. L., et al.
Publicado: (2015) -
Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
por: van der Heijden, Martijn, et al.
Publicado: (2020)